Literature DB >> 20797846

Psychological consequences of lymphoedema associated with breast cancer: a prospective cohort study.

Ditte Vassard1, Maja Halgren Olsen, Line Zinckernagel, Jette Vibe-Petersen, Susanne Oksbjerg Dalton, Christoffer Johansen.   

Abstract

BACKGROUND: The aim of this prospective cohort study of women attending a rehabilitation course at the Dallund Rehabilitation Centre was to explore the emotional and psychological aspects of living with lymphoedema, expressed as psychological distress, poorer quality of life and poorer self-reported health.
METHODS: Between November 2002 and January 2007 within the FOCARE study, self-completed questionnaires were collected 3 weeks before and 6 and 12 months after the rehabilitation course to elicit sociodemographic, physical and lifestyle information and responses to three psychometric tests. The population consisted of 633 women, 125 with and 508 without verified lymphoedema (time since surgery, 1 month-5 years). The population was reduced to 553 women at the first follow-up and 494 at the second.
RESULTS: Multivariate analysis showed that, in comparison with women without lymphoedema, those with lymphoedema had a 14% higher risk for scoring one level higher on the POMS-SF test, a 9% higher probability of scoring one point lower on the quality of life scale and a 29% higher likelihood of reporting poorer or bad health than women without lymphoedema. These findings were seen at all three measurement times.
CONCLUSIONS: In this cohort of women with breast cancer, women with lymphoedema after surgery for breast cancer had significantly worse overall emotional well-being and adjustment to life compared to women without lymphoedema.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20797846     DOI: 10.1016/j.ejca.2010.07.041

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  21 in total

Review 1.  Symptom management in metastatic breast cancer.

Authors:  William Irvin; Hyman B Muss; Deborah K Mayer
Journal:  Oncologist       Date:  2011-08-31

2.  Timing of Lymphedema After Treatment for Breast Cancer: When Are Patients Most At Risk?

Authors:  Susan G R McDuff; Amir I Mina; Cheryl L Brunelle; Laura Salama; Laura E G Warren; Mohamed Abouegylah; Meyha Swaroop; Melissa N Skolny; Maria Asdourian; Tessa Gillespie; Kayla Daniell; Hoda E Sayegh; George E Naoum; Hui Zheng; Alphonse G Taghian
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-08-28       Impact factor: 7.038

3.  Randomised controlled trial to determine the benefit of daily home-based exercise in addition to self-care in the management of breast cancer-related lymphoedema: a feasibility study.

Authors:  Eunice Jeffs; Theresa Wiseman
Journal:  Support Care Cancer       Date:  2012-10-17       Impact factor: 3.603

Review 4.  Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011.

Authors:  Mei R Fu; Sheila H Ridner; Sophia H Hu; Bob R Stewart; Janice N Cormier; Jane M Armer
Journal:  Psychooncology       Date:  2012-10-09       Impact factor: 3.894

5.  Factors predicting adherence to risk management behaviors of women at increased risk for developing lymphedema.

Authors:  Kerry A Sherman; Suzanne M Miller; Pagona Roussi; Alan Taylor
Journal:  Support Care Cancer       Date:  2014-06-27       Impact factor: 3.603

6.  How people construct their experience of living with secondary lymphoedema in the context of their everyday lives in Australia.

Authors:  Judith A Meiklejohn; Kristiann C Heesch; Monika Janda; Sandra C Hayes
Journal:  Support Care Cancer       Date:  2012-07-18       Impact factor: 3.603

7.  Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Crystal S Denlinger; Tara Sanft; K Scott Baker; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Melissa Hudson; Nazanin Khakpour; Allison King; Divya Koura; Robin M Lally; Terry S Langbaum; Allison L McDonough; Michelle Melisko; Jose G Montoya; Kathi Mooney; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; William Pirl; M Alma Rodriguez; Kathryn J Ruddy; Paula Silverman; Sophia Smith; Karen L Syrjala; Amye Tevaarwerk; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Nicole R McMillian; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2018-10       Impact factor: 11.908

Review 8.  Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.

Authors:  Tessa C Gillespie; Hoda E Sayegh; Cheryl L Brunelle; Kayla M Daniell; Alphonse G Taghian
Journal:  Gland Surg       Date:  2018-08

Review 9.  Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes.

Authors:  Andrea L Pusic; Yeliz Cemal; Claudia Albornoz; Anne Klassen; Stefan Cano; Isabel Sulimanoff; Marisol Hernandez; Marga Massey; Peter Cordeiro; Monica Morrow; Babak Mehrara
Journal:  J Cancer Surviv       Date:  2012-12-05       Impact factor: 4.442

10.  Living with lymphoedema-the perspective of cancer patients: a qualitative study.

Authors:  Ángela Río-González; Francisco Molina-Rueda; Domingo Palacios-Ceña; Isabel M Alguacil-Diego
Journal:  Support Care Cancer       Date:  2018-01-12       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.